<DOC>
	<DOCNO>NCT01335139</DOCNO>
	<brief_summary>The purpose research study investigate whether sublingual immunotherapy ( SLIT , grass pollen tablet tongue ) long term effect severe hay fever .</brief_summary>
	<brief_title>Long-Term Effects Sublingual Grass Therapy</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>A clinical history grass polleninduced allergic rhinoconjunctivitis least 2 year peak symptom May , June , July . A clinical history moderate severe rhinoconjunctivitis symptom interfere usual daily activity sleep define accord ARIA classification rhinitis . A clinical history rhinoconjunctivitis least 2 year require treatment either antihistamine nasal corticosteroid grass pollen season . Positive skin prick test response , define wheal diameter great equal 3 mm , Phleum pratense . Positive specific IgE , define great equal IgE class 2 ( 0.7 kU/L ) , Phleum pratense . A positive response nasal allergen challenge Phleum pretense , define increase TNSS great equal 7 point baseline . For woman childbearing age , willingness use effective form contraception duration trial . The ability give inform consent comply study procedure . Prebronchodilator FEV1 le 70 % predict value either screen baseline visit . A clinical history moderate severe allergic rhinitis , accord ARIA classification , due tree pollen near overlap grass pollen season.1 A clinical history persistent asthma and/or require regular inhaled corticosteroid &gt; 4 week per year outside grass pollen season . A clinical history moderate severe allergic rhinitis , accord ARIA classification , cause allergen participant regularly exposed.1 History emergency visit hospital admission asthma previous 12 month . History chronic obstructive pulmonary disease . History significant recurrent acute sinusitis , define 2 episode per year last 2 year , require antibiotic treatment . History chronic sinusitis , define sinus symptom last great 12 week include 2 major factor 1 major factor 2 minor factor . Major factor define facial pain pressure , nasal obstruction blockage , nasal discharge purulence discolor postnasal discharge , purulence nasal cavity , impaired loss smell . Minor factor define headache , fever , halitosis , fatigue , dental pain , cough , ear pain , pressure , fullness . At randomization , current symptom , treatment , upper respiratory tract infection , acute sinusitis , acute otitis medium , relevant infectious process ; serous otitis medium exclusion criterion . Participants may reevaluate eligibility symptom resolve . Any tobacco smoking within last 6 month history great equal 10 pack year . Previous treatment immunotherapy grass pollen allergen within previous 5 year . Any history grade 4 anaphylaxis due cause define WAO grade criterion immunotherapy ( see appendix 7 ) . History bleed disorder treatment anticoagulation therapy History antiIgE monoclonal antibody treatment . Ongoing systemic immunosuppressive treatment . History intolerance study therapy , rescue medication , excipients . For woman childbearing age positive serum urine pregnancy test sensitivity le 50 mIU/mL within 72 hour start study therapy . The use investigational drug within 30 day screen visit . The presence medical condition investigator deem incompatible participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>sublingual immunotherapy</keyword>
	<keyword>subcutaneous immunotherapy</keyword>
</DOC>